TD Asset Management’s Senti Biosciences Holdings SNTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-731
Closed -$102K – 1441
2023
Q3
$102K Buy
731
+343
+88% +$77.9K ﹤0.01% 1384
2023
Q2
$79.8K Buy
388
+30
+8% +$9.7K ﹤0.01% 1389
2023
Q1
$140K Hold
358
– – ﹤0.01% 1395
2022
Q4
$167K Sell
358
-51
-12% -$41.1K ﹤0.01% 1399
2022
Q3
$285K Buy
409
+143
+54% +$93K ﹤0.01% 1374
2022
Q2
$172K Buy
+266
New +$705K ﹤0.01% 1392
2021
Q4
– Sell
-266
Closed -$872K – 1541
2021
Q3
$872K Hold
266
– – ﹤0.01% 1282
2021
Q2
$863K Buy
+266
New +$876K ﹤0.01% 1290

Other funds holding SNTI

TD Asset Management's SNTI Position: Q4 2023 in Review

TD Asset Management sold out of Senti Biosciences Holdings (SNTI) in Q4 2023, closing a stake of 731 shares — an estimated $102K sold.

TD Asset Management first reported a position in SNTI in Q2 2021 and held it in 8 quarters. The position peaked at $872K in Q3 2021. 23 funds tracked by Wall St. Rank hold SNTI as of Q4 2023.

  • TD Asset Management reported no remaining Senti Biosciences Holdings position as of Q4 2023 after selling out during the quarter.
  • TD Asset Management sold 731 Senti Biosciences Holdings shares in Q4 2023, an estimated $102K.
  • TD Asset Management first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 8 quarters.
  • TD Asset Management's Senti Biosciences Holdings position peaked at $872K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2023.

Based on TD Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.